# Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers

> **NCT06435689** · — · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 500 (estimated)

## Conditions studied

- Colon Cancer
- Peritoneal Carcinoma

## Interventions

- **OTHER:** Sampling

## Key facts

- **NCT ID:** NCT06435689
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-15
- **Primary completion:** 2025-06-15
- **Final completion:** 2039-06-15
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06435689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06435689, "Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06435689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*